Learning objectives: Hereditary ATTR amyloidosis treatment.

Advances in gene editing therapy.

Session date: 
04/26/2022 - 12:00pm to 1:00pm CDT
Location: 
Virtual/P-117
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Julian Gillmore, MD, PhD, FRCP, FRCPath